ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
61,579.07
-0.38%
S&P 500
5,460.19
-0.17%
Dow Jones
39,041.76
-0.18%
US Dollar vs Yen
160.60
0.57%
Brent Oil
84.42
0.28%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Cytokinetics Inc (CYTK)

  7. Cytokinetics Inc (CYTK) ニュース

CYTK

Cytokinetics (CYTK)

Cytokinetics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:CYTK
日付受信時刻ニュースソース見出しコード企業名
2024/06/1806 : 22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CYTKCytokinetics Inc
2024/06/1806 : 17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CYTKCytokinetics Inc
2024/06/1806 : 13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CYTKCytokinetics Inc
2024/06/1805 : 24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CYTKCytokinetics Inc
2024/06/1720 : 30GlobeNewswire Inc.Cytokinetics Announces Initiation of Phase 1 Study of Aficamten in Healthy Japanese ParticipantsNASDAQ:CYTKCytokinetics Inc
2024/06/1206 : 16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CYTKCytokinetics Inc
2024/06/1205 : 22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CYTKCytokinetics Inc
2024/06/1106 : 08Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CYTKCytokinetics Inc
2024/06/1105 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CYTKCytokinetics Inc
2024/06/0806 : 13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYTKCytokinetics Inc
2024/06/0805 : 03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CYTKCytokinetics Inc
2024/06/0606 : 23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CYTKCytokinetics Inc
2024/06/0523 : 02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYTKCytokinetics Inc
2024/06/0505 : 30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CYTKCytokinetics Inc
2024/06/0505 : 24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CYTKCytokinetics Inc
2024/06/0505 : 00GlobeNewswire Inc.Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CYTKCytokinetics Inc
2024/06/0406 : 07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CYTKCytokinetics Inc
2024/06/0405 : 36Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CYTKCytokinetics Inc
2024/06/0405 : 33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CYTKCytokinetics Inc
2024/06/0405 : 25Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CYTKCytokinetics Inc
2024/06/0405 : 20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CYTKCytokinetics Inc
2024/06/0405 : 01Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CYTKCytokinetics Inc
2024/05/3005 : 00GlobeNewswire Inc.Cytokinetics to Participate in June Investor ConferencesNASDAQ:CYTKCytokinetics Inc
2024/05/2905 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYTKCytokinetics Inc
2024/05/2905 : 00GlobeNewswire Inc.Cytokinetics Announces Closing of Public Offering of Common StockNASDAQ:CYTKCytokinetics Inc
2024/05/2505 : 56Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CYTKCytokinetics Inc
2024/05/2320 : 40IH Market NewsOpenAI and News Corp Seal Partnership, DuPont de Nemours Announces Division, and More NewsNASDAQ:CYTKCytokinetics Inc
2024/05/2312 : 30GlobeNewswire Inc.Cytokinetics Announces Pricing of Public Offering of Common StockNASDAQ:CYTKCytokinetics Inc
2024/05/2305 : 55Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CYTKCytokinetics Inc
2024/05/2305 : 15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYTKCytokinetics Inc
 Showing the most relevant articles for your search:NASDAQ:CYTK

最近閲覧した銘柄

USOTC
BASFY
BASF (QX)
USI
USTECH100
US Tech 100
NYSE
CVX
Chevron
NYSE
AXP
American Express
NYSE
NKE
Nike
NYSE
JPM
JP Morgan Chase
CCOM
SILVER
SILVER
NYSE
BAC
Bank of America
CCOM
US100
US Tech 100
NASDAQ
QQQ
Invesco QQQ Trust Series 1
FX
USDEUR
US Dollar vs Euro
NASDAQ
AMZN
Amazon.com
NYSE
VZ
Verizon Communications
AMEX
SPY
SPDR S&P 500
COIN
BTCUSD
Bitcoin
FX
USDGBP
US Dollar vs Sterling
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有